Vancouver ↔ Seoul | Cross-Border Commercialization

Bridging North American MedTech Innovation with South Korea

Helping North American MedTech companies successfully enter the Korean healthcare market through strategic market access, Key Opinion Leader (KOL) engagement, and accelerated commercialization specialized in gastroenterology and GI health.

Schedule a Consultation Explore Market Data

Cross-Border Infrastructure

Seamless Market Access Corridor

Linking innovative medical device technology with top-tier university hospitals and GI Key Opinion Leaders across South Korea.

North American Origin Vancouver HQ

Target Asian Market Seoul Commercial Hub

Regulatory Advantage Fast-Track / Immediate Entry

Clinical Focus Area Gastroenterology (GI) Healthcare

Market Opportunity

Unlocking South Korea's High-Growth GI Market

South Korea represents one of the most dynamic, high-volume healthcare markets for gastroenterology innovation in Asia.

100,000+

Diagnosed IBD Patients

Over the past decade, Inflammatory Bowel Disease (Crohn’s Disease & Ulcerative Colitis) prevalence in South Korea has surged rapidly, surpassing 100,000+ registered patients due to Westernized lifestyle shifts.

Millions

Annual Colonoscopies

Backed by South Korea’s National Cancer Screening Program, millions of screening and therapeutic endoscopies are conducted annually, driving sustained demand for advanced diagnostic and therapeutic devices.

Rapid

Clinical Technology Adoption

Top-tier university hospital GI centers in South Korea offer world-class clinical efficiency and eager technology adoption by leading global Key Opinion Leaders (KOLs).

Target Portfolio Criteria

Focus GI Solution Categories

VanKor specializes in commercializing FDA-cleared and clinically validated North American medical technologies across three core gastroenterology domains:

Continence & Bowel Dysfunction

Non-surgical, discreet internal continence inserts and post-operative recovery solutions designed for accidental bowel leakage (ABL), neurogenic bowel care, and colorectal surgical rehabilitation.

Key Fit: Minimally Invasive Patient-Centered Care

GI Motility & Monitoring

Wearable, wireless sensor patch systems providing real-time electrogastrography (EGG) and gut bio-electric activity monitoring for gastroparesis, chronic constipation, and post-operative ileus (POI).

Key Fit: Real-Time Diagnostic Clinical Evidence

Capsule & Endoscopic Diagnostics

Next-generation 360° panoramic capsule endoscopy and specialized endoscopic adapters enhancing diagnostic precision for IBD (Crohn’s & Ulcerative Colitis) and small bowel pathologies.

Key Fit: High-Volume Screening Infrastructure

Leadership & Clinical Advisory

Proven Multinational Commercial Track Record

Helmed by commercial leaders with extensive leadership experience at premier global healthcare and life sciences multinationals, ensuring top-tier execution for North American products in South Korea.

Vancouver, Canada

Minwoo Lee

Founding Partner

10+ Years Experience

Leveraging commercial leadership roles at premier global healthcare corporations including Johnson & Johnson (IBD Commercial) and Merck (Primary Care), Minwoo possesses the top-tier strategic capability required to successfully introduce and position North American medical technologies in the South Korean market.

Grounded in 10+ years of healthcare strategy and quantitative discipline from UNC Chapel Hill (Mathematics & Statistics), Minwoo orchestrates strategic alignment between foreign device manufacturers and premier Korean gastroenterology centers.

Core Expertise

Global Pharma & MedTech Leadership KOL Engagement Cross-Border Expansion

Seoul, South Korea

Co-Founder

Market Access & Operations

20+ Years Experience

A seasoned healthcare executive with over 20+ years of comprehensive commercial experience spanning top global pharmaceutical, medical device, and life science leaders including Johnson & Johnson, Pfizer, and Thermo Fisher Scientific.

Possesses an extensive track record across Sales & Marketing, Market Access, Regulatory Affairs, and Reimbursement Strategy, ensuring seamless market entry and rapid clinical adoption in top-tier South Korean hospital systems.

Core Expertise

Global Multinationals (J&J, Pfizer, ThermoFisher) Market Access & HIRA Sales & Marketing Leadership

🩺

Active Clinical Advisory Board

Guided by practicing clinicians and gastroenterologists in Canada and South Korea to validate technology fit and regulatory pathways.

Canadian Practicing Physicians South Korean GI Clinicians

Core Capabilities

End-to-End Market Access Solutions

Fast-Track & Market Access

Navigating MFDS approvals and leveraging South Korea’s Immediate Market Entry & New Health Technology Exemption Pathways to drastically shorten time-to-market and accelerate non-reimbursed clinical adoption.

KOL Engagement & Clinical Adoption

Connecting innovative MedTech products directly with premier gastroenterology professors and clinical testing centers to accelerate adoption.

Strategic Distribution Setup

Establishing vetted local distribution networks and commercial execution plans to secure sustainable long-term market presence.

Ready to Expand Your MedTech Reach into South Korea?

Partner with VanKor MedTech Solutions to accelerate market access and build trusted clinical relationships in Asia.

Contact Information

Company VanKor MedTech Solutions

Founding Partner Minwoo Lee (Vancouver)

Co-Founder Seoul, South Korea

Email minwoo@vankormed.com

Website www.vankormed.com

Locations Greater Vancouver, BC | Seoul, South Korea

Send Direct Email

Connect on LinkedIn

Scan QR code to connect directly with Minwoo Lee on LinkedIn

Open LinkedIn Profile →